Compare Occidental Petroleum Corporation (OXY) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Occidental Petroleum Corporation vs Sanofi SA — how do they compare? Occidental Petroleum Corporation trades at $61.53 (market cap $61.28B), while Sanofi SA trades at $42.95 (market cap $103.41B). The key difference: Sanofi SA is the larger of the two by market cap, and Sanofi SA pays the higher dividend (5.65%). Which is the better fit depends on your goals.
| OXY | SNY | |
|---|---|---|
Market Cap | $61.28B | $103.41B |
Sector | Energy | Health |
52-Week High | $66.24 | $52.34 |
52-Week Low | $38.92 | $41.33 |
Enterprise Value | $80.04B | $123.44B |
Dividend Yield | 1.83% | 5.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Occidental Petroleum (OXY) trades at $60.65, up 1.02% today, with a bullish technical signal from moving averages and a consensus analyst price target of $68.67. The company has beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.40 surpassing expectations of $1.83. Financials show strong profitability with a 30.32% net income margin and robust cash flow from operations of $10.53 billion in 2025, though revenue has declined from $36.6 billion in 2022 to $21.6 billion in 2025.
OXY presents a positive outlook with debt reduction progress and projected net income margin rebound to 30.31% in 2026. Investment opportunities include potential upside to the price target and sustainable cash flow growth. Risks include oil price volatility, geopolitical tensions affecting energy markets, and execution challenges in maintaining profitability amid fluctuating revenues.
SNY trades at $43.16, down 2.45% today, with a bearish technical signal from moving averages but bullish oscillators. The company reported Q2 2026 EPS of $1.21, beating expectations, and raised its 2026 outlook driven by Dupixent strength. Financials show improved net income of $7.81B in 2025, with a P/E of 22.94 and net margin of 8.09%.
Outlook is mixed: strong drug performance and analyst hold ratings suggest stability, but pipeline setbacks and projected 2026 profit margin decline to 8.09% pose risks. The stock offers a 5.4% dividend yield, trading below sector P/E, presenting value if growth execution offsets challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
